2-Benzoyl-4-nitroanilides and their use as medicaments

Abstract

1. New derivatives of 2-benzoyl-4-nitro-anilides corresponding to the following general formula : see diagramm : EP0022017,P12,F1 in which R represents a linear or branched alkyl group, an alkenyl group, a cycloalkyl group or a benzyl group ; R1 represents a hydrogen atom, an alkyl or hydroxy alkyl group ; R2 represents a hydroxy alkyl, alkenyl or alkynyl group optionally substituted once or several times by an alkyl radical or a cycloalkyl group containing from 3 to 6 carbon atoms ; R1 and R2 may in additon form with the nitrogen atom to which they are attached a nitrogen-containing heterocycle optionally containing a second heteroatom selected from oxygen and nitrogen ; with the proviso that, where R2 is a hydroxy alkyl group, R1 cannot be a hydrogen atom, and their salts obtained with therapeutically acceptable mineral or organic acids.

What is claimed is: 
     
       1. 2-benzoyl-4-nitro anilides having the formula I: ##STR24## in which R represents alkyl, alkenyl, cycloalkyl, or benzyl; R 1  represents hydrogen, alkyl or hydroxyalkyl;   R 2  represents hydroxyalkyl, alkenyl or alkynyl, unsubstituted or substituted one or more times by an alkyl radical, or cycloalkyl having three to six carbon atoms, inclusive;   R 1  and R 2  may furthermore form, with the nitrogen atom to which they are attached, a nitrogen heterocycle which may also contain a second heteroatom selected from oxygen and nitrogen;   provided, however that, when R 2  represents hydroxyalkyl, R 1  may not be hydrogen, as well as their salts obtained with therapeutically acceptable inorganic or organic acids.   
     
     
       2. Compounds of formula I in accordance with claim 1, characterized by the fact that they are selected from among N-methyl-2'-benzoyl-4'-nitro-2-morpholino acetanilide hydrochloride,   acid maleate of N-ethyl-2'-benzoyl-4'-nitro-2-morpholino acetanilide,   acid maleate of N-propyl-2'-benzoyl-4'-nitro-2-morpholino acetanilide.   acid maleate of N-isopropyl-2'-benzoyl-4'-nitro-2-morpholino acetanilide.   maleate of N-allyl-2'-benzoyl-4'-nitro-2-morpholino acetanilide,   N-benzyl-2'-benzoyl-4'-nitro-2- morpholino acetanilide,   N-cyclopropyl-2'-benzoyl-4'-nitro-2-morpholino acetanilide,   N-cyclopentyl-2'-benzoyl-4'-nitro-2-morpholino acetanilide,   N-cyclohexyl-2'-benzoyl-4'-nitro-2-morpholino acetanilide,   N-cyclohexyl-N'-methyl-2'-benzoyl-4'-nitro glycylanilide hydrochloride,   N,N'-dimethyl-N-cyclohexyl-2'-benzoyl-4'-nitroglycylanilide fumarate;   N'-methyl-N-cyclopropyl-2'-benzoyl-4'-nitroglycylanilide,   N'-methyl-N-1,1-dimethyl propargyl 2'-benzoyl-4'-nitro glycylanilide,   N'-methyl-N-allyl-2'-benzoyl-4'-nitro glycylanilide,   N,N'-dimethyl-N-(2-hydroxy ethyl)-2'-benzoyl-4'-nitro-glycylanilide,   N'-methyl-N,N-bis-(2-hydroxy ethyl)-2'-benzoyl-4'-nitro glycylanilide, and   N-methyl-2-(4'-methylpiperazino)-(2'-benzoyl-4'-nitro) acetanilide.   
     
     
       3. A compound of claim 1 selected from the group consisting of 2'-benzoyl-4'-nitro-2-morpholinoacetanilides and the pharmaceutically-acceptable acid addition salts thereof, having an N-substituent selected from the group consisting of lower-alkyl, lower-alkenyl, benzyl, and cycloalkyl having a maximum of six (6) carbon atoms in the ring. 
     
     
       4. A compound of claim 1 selected from the group consisting of 2'-benzoyl-4'-nitro-glycylanilides, and the pharmaceutically-acceptable acid addition salts thereof, having one N-substituent selected from the group consisting of lower-alkenyl, cycloalkyl having a maximum of six (6) carbon atoms in the ring, lower-alkynyl, and hydroxylower-alkyl, and having the other N-substituent selected from hydrogen, lower alkyl and hydroxy lower alkyl and having an N'-substituent which is lower-alkyl. 
     
     
       5. A pharmaceutical composition suitable for use as a hypnotic comprising an effective hypnotic amount of a compound of claim 1 or claim 2 in combination with a pharmaceutically acceptable carrier or adjuvant. 
     
     
       6. Method for the treatment of a subject suffering from insomnia, comprising the step of administering to the said subject an effective hypnotic amount of a compound of claim 1 or 2.